908 Devices Inc

908 Devices Inc(MASS)股票分析

$10.670

+0.481 (+4.51%)收盤時

Loading chart…
最高
10.930
開盤
10.350
成交量加權均價
10.60
成交量
308.56K
市值
177.60M
最低
10.210
成交金額
3.27M
企業價值/稅息折舊攤銷前利潤(TTM)
-12.98

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

AI 分析 of 908 Devices Inc (MASS)

持有

While 908 Devices Inc. (MASS) has shown a remarkable year-to-date change of +100.59%, the current price of $10.21 is below the average analyst price target of $12.75, suggesting potential upside. However, the RSI is at 26.067, indicating that the stock is oversold, which may signal a potential rebound. The main risk is the recent 5-day change of -12.36%, reflecting volatility and potential downward pressure.

估值指標

908 Devices Inc(MASS)目前預期本益比為 0.00,5 年平均預期本益比為 -9.76。

預期本益比

高估
5 年均值 P/E
-9.76
目前P/E
0.00
高估
-2.60
低估
-16.92

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-7.54
目前EV/EBITDA
-12.98
高估
2.10
低估
-17.18

預期股價營收比

合理
5 年均值 P/S
5.84
目前P/S
5.11
高估
9.89
低估
1.79

Alphio AI 對 MASS 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%MASS

$6.47

情境價格

基

基準

基準 · 50%MASS

$6.04

情境價格

悲

悲觀

悲觀 · 25%MASS

$5.05

情境價格

持有 MASS 的大戶

A

Arch Venture Partners, L.P.

+ 持有MASS

-18.10%

3個月報酬率

事件時間軸

2026-08-11 (ET)

07:30:00

Q2 Revenue of $16.1M Exceeds Expectations

2026-05-06 (ET)

07:40:00

Company Reports Q1 Revenue of $13.4M, Acquires NIRLAB AG

07:30:00

908 Devices Completes Acquisition of NIRLAB AG for $15 Million

2026-04-21 (ET)

17:10:00

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer

2026-03-09 (ET)

07:00:00

908 Devices Files $100M Mixed Securities Shelf

資訊

MASS 常見問題 —— 由 Alphio AI 解答

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds. It operates in the Healthcare sector (MEASURING & CONTROLLING DEVICES, NEC industry).

While 908 Devices Inc. (MASS) has shown a remarkable year-to-date change of +100.59%, the current price of $10.21 is below the average analyst price target of $12.75, suggesting potential upside. However, the RSI is at 26.067, indicating that the stock is oversold, which may signal a potential rebound. The main risk is the recent 5-day change of -12.36%, reflecting volatility and potential downward pressure.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易